The necessity of unification and addition of instructions on the use of medicinal products is found out as follows.
The "Indications" section should contain the following information: chronic obstructive pulmonary disease, chronic bronchitis, emphysema, bronchial asthma (mild and moderate severity), especially with concomitant diseases of the cardiovascular system.
In the section "Contraindications," the division of contraindications by age for different dosage forms of drugs with INN "ipratropium bromide" should be justified by clinical studies and the doses required for the treatment of children of the appropriate age. The section should contain a contraindication: pregnancy (I trimester).
The section "With caution" should include: pregnancy (II and III trimesters), the period of breastfeeding.